The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural ...

Despite Stryker’s underperformance relative to its peers over the past year, Wall Street analysts remain moderately ...

Think Surgical today announced the first completed cases using the TMINI miniature robotic system with the Stryker Triathlon knee system.

Stryker (NYSE:SYK) has said in an SEC filing that probes into potential anti-bribery law violations have been ended by ...

Medical device maker Stryker Corp. won’t have to defend a proposed class action alleging its employee non-compete agreements violate Washington state law, a federal court said.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $426.14, along ...

Stryker is expanding its footprint in orthopedic innovation with the launch of Mako Handheld Robotics and a limited release of ...

Medical technology company Stryker (NYSE:SYK) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.4% year on year to $7.17 billion. Its non-GAAP profit of $4.47 per ...

SYK launches Synchfix EVT, a next-gen ankle fixation system designed to streamline surgery and expand reach into adolescent ...